Arkolith/Insider Trading/CTIC/Form 4

Fong James K

EVP & Chief Commercial OfficerCTI BIOPHARMA CORP (CTIC) · full profile →Form 4 · filed Jan 26, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$600K
Net Open-Market Flow
-$600K
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 24, 2023Sell(S)100K$6.00$600K4K
Jan 24, 2023Option exercise(M)100K$0.95$95K104K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 24, 2023Option exercise(M)100K—$0188K
Feb 19, 2019Grant(A)288K—$0288K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000891293-23-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML